Re-Irradiation of Recurrent Head and Neck Cancers Using Pulsed Reduced Dose Rate Radiotherapy: An Institutional Series

Author:

Megahed Romy,Prabhu Arpan V.,Mack Delanie P.,Gholami Somayeh,Samanta Santanu,Patel Mausam,Lewis Gary D.

Abstract

AbstractPurpose/Objective(s)Pulsed reduced dose rate (PRDR) radiation (RT) is a re-irradiation (Re-RT) technique that potentially overcomes dose/volume constraints in the setting of previous radiation therapy. While the use of this Re-RT technique has been reported for other disease sites, there is minimal data for its use for recurrent or secondary primary squamous cell carcinoma of the head and neck (HNSCC). In this study, we report preliminary data from our institution of a consecutive cohort of patients with HNSCC who received PRDR Re-RT.Materials/MethodsOut of 11 patients who received PRDR Re-RT from August 2020 to January 2023, 9 had analyzable data. Intensity modulated RT was used for treatment delivery using either volume modulated arc therapy or helical tomotherapy. A wait time between 20cGy arc/helical deliveries was used to achieve the effective low dose rate. Data collected included patient demographic information, prior interventions, diagnosis, radiation therapy dose and fractionation, progression free survival, overall survival, and toxicity rates.ResultsThe median time to PRDR from completion of initial RT was 13 months (range, 6-50 months). All but one patient underwent salvage surgery prior to PRDR. In total, 4 patients received systemic therapy as part of their re-treatment courses. The median follow-up after Re-RT was 7 months. The median OS from PRDR was 7 months (range, 1-32 months). Median PFS was 7 months (range, 1-32 months). One patient (11.1%) had acute grade 3 toxicity, and two patients (22.2%) had late grade 3 toxicities. There were no acute or late grade 4 or 5 toxicities.ConclusionPRDR for Re-RT is a feasible treatment strategy for patients with recurrent or second primary HNSCC. Initial findings from this retrospective review suggest reasonable survival outcomes and potentially improved toxicity; prospective data is needed to establish the safety and efficacy of this technique.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3